Ignite Creation Date:
2024-05-06 @ 8:08 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06262438
Status:
RECRUITING
Last Update Posted:
2024-02-16
First Post:
2024-01-26
Brief Title:
CHIP-AML22Quizartinib Quizartinib Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD and NPM1wt AML Patients
Sponsor:
Princess Maxima Center for Pediatric Oncology
Organization:
Princess Maxima Center for Pediatric Oncology
Organization Data
Organization:
Princess Maxima Center for Pediatric Oncology
Class:
OTHER
Study ID:
MH22CAQ
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Princess Maxima Center for Pediatric Oncology
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Daiichi Sankyo | INDUSTRY |